Publication
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas.
Journal Paper/Review - Aug 19, 2021
Pirosa Maria C, Zhang Lu, Hitz Felicitas, Novak Urban, Hess Dagmar, Terrot Tatiana, Pascale Mariarosa, Mazzucchelli Luca, Bertoni Francesco, Cavalli Franco, Zucca Emanuele, Stathis Anastasios
Pirosa, Maria C
1
0
Zhang, Lu
1
0
Hitz, Felicitas
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I
52
32
Novak, Urban
17
0
Hess, Dagmar
Medizinische Onkologie und Hämatologie · Dept. I
26
17
Terrot, Tatiana
1
0
Pascale, Mariarosa
2
0
Mazzucchelli, Luca
5
0
Bertoni, Francesco
10
0
Cavalli, Franco
8
0
Zucca, Emanuele
19
0
Stathis, Anastasios
8
0